Island Pharmaceuticals (ASX:ILA)
ASX announcement history & article coverage
Transparent by design.
Announcments by Island Pharmaceuticals (ASX:ILA) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Notification regarding unquoted securities - ILA
Galidesivir GMP manufacturing commences
Island commences GMP Galidesivir production for Ebola program and planned Marburg study
Annual General Meeting - Rescheduled Date
Pivotal Marburg data secured for Galidesivir FDA pathway
Island Pharmaceuticals secures key Marburg data for Galidesivir FDA approval pathway
Appendix 4G and Corporate Governance Statement
Annual Report to shareholders
Island Pharmaceuticals advances Galidesivir antiviral program with FDA pathway and strengthened finances in FY26
Preliminary Final Report
Island Pharmaceuticals reports higher income but increased loss for FY 2026
Island boosts Galidesivir supply as Ebola surges
Island Pharmaceuticals expands Galidesivir supply to support Ebola outbreak response and biodefence
Date of AGM & Closing Date for Director Nominations
Cleansing Notice
Application for quotation of securities - ILA
Investor presentation
Quarterly Appendix 4C and Activities Report
Island Pharmaceuticals advances Galidesivir program with FDA orphan drug status, GMP manufacturing, and Ebola outbreak approvals
Investor Presentation - TechKnow Invest Roadshow